ASCO: AstraZeneca looks to bring immunotherapy to early-stage stomach cancer with Imfinzi
AstraZeneca’s Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to results from a phase 3 study.

Jun 2, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
May 30, 2025 0
May 30, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
Jun 1, 2025 0
Jun 1, 2025 0
Jun 1, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
Jun 2, 2025 0
May 27, 2025 0
May 27, 2025 0
Jun 2, 2025 0
Or register with email
May 15, 2025 0
May 12, 2025 0
May 12, 2025 0
May 12, 2025 0
May 12, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.